Jennifer M. Carter is Director & 10% Owner at Augmedix, Inc. (NONE). They have made 2 open-market trades across 2 companies since 2020, most recently 2021-10-28.
CIK 0001826113
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $2.3M since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AUGX | 4,022,606 | $9.5M |
| PrivateUnlisted | 3,268,440 | — |
| Total | $9.5M |
Shares reported on the most recent Form 4, priced at the 2021-11-01 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AUGX | BUY | 2021-10-28 | 2021-11-01 | $4.00 | $350K | +1.3% | -16.2% | -34.8% |
| PrivateAugmedix, Inc. | BUY | 2020-10-05 | 2020-10-07 | $3.00 | $2.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.